ACTIVE

PHARMA BASE

Financial year 2024 · closed on 31/12/2024
Net result
178,9 k €
+327.6% YoY
Revenue
75,2 M €
+25.1% YoY
Equity
2,5 M €
+7.6% YoY
Workforce
29,0 ETP
+26.1% YoY

What does PHARMA BASE do?

PHARMA BASE is a Public limited company incorporated in 1990. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Genk. It employs on average 29,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0441.943.282
Incorporation
10/10/1990
Legal form
Public limited company
Registered office
Seinhuisstraat 7 box 1
3600 Genk · FlandreSee on map
Contributed capital
1 000 000,00 €
Latest accounts
31/12/2024
Average workforce
29,0 ETP
Joint committees (2)
  • 313
  • 321
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 13 financial years

2024202320222021202020192018201720102009200820072006
Income statement
Revenue75,2 M €60,2 M €52,1 M €56,2 M €56,8 M €46,4 M €32,8 M €42 M €27 M €21,3 M €22,2 M €27,4 M €31,2 M €
EBITDA480,1 k €349,3 k €422,7 k €787,9 k €601,8 k €1,1 M €2,3 M €701 k €1,1 M €472,1 k €179,8 k €86,4 k €41,4 k €
Operating result364,8 k €241,1 k €301,2 k €651,9 k €501,3 k €1 M €2,2 M €602,8 k €1,1 M €390,8 k €50,6 k €3,9 k €-28,1 k €
Net result178,9 k €41,8 k €147,3 k €485,5 k €327,2 k €674 k €935,5 k €275,4 k €728,4 k €20,8 k €-6,9 k €-102 k €-61,9 k €
Balance sheet
Equity2,5 M €2,3 M €2,3 M €4,2 M €3,7 M €3,3 M €2,7 M €1,7 M €858 k €203,1 k €182,3 k €189,2 k €291,2 k €
Total assets21,1 M €19,1 M €19,9 M €17,5 M €18,3 M €19,8 M €14,6 M €10,8 M €9,8 M €7,1 M €7,3 M €6,4 M €7,2 M €
Cash645,1 k €1,7 M €1,2 M €2 M €828,5 k €75,3 k €11 k €186,7 k €7,9 k €159,7 k €623,1 k €573,2 k €175,5 k €
Debts18,5 M €16,7 M €17,5 M €13,4 M €14,7 M €16,5 M €11,9 M €9 M €8,5 M €6,8 M €7 M €6,1 M €6,8 M €
Other
Workforce29,0 ETP23,0 ETP18,8 ETP17,3 ETP15,1 ETP11,6 ETP8,8 ETP8,9 ETP8,7 ETP7,0 ETP6,0 ETP4,8 ETP4,2 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 31 ended

Active mandates

peeters mathieu management

Director · since 31 décembre 2022 · 0876.728.461

Represented by Mathieu Peeters

Active

Ended mandates

peeters mathieu management

Director · since 31 décembre 2022 · until 31 décembre 2028 · 0876.728.461

Represented by Mathieu Peeters

Ended
BXI

Director · since 13 juillet 2018 · until 31 décembre 2022 · 0890.875.021

Represented by Ivo Lemmens

Ended
BXI

Director · since 13 juillet 2018 · until 13 juillet 2024 · 0890.875.021

Represented by Ivo Lemmens

Ended
BXI

Director · since 13 juillet 2018 · until 13 juillet 2024 · 0890.875.021

Represented by Ivo Lemmens

Ended
At this address

Other companies at this address

CompanyCBE no.
EM GROUPBankrupt
0890.621.435
INBAActive
0807.199.257
Annual accounts

Full financial information

202420232022202120202019
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202531/07/202411/07/202322/06/202224/06/202116/07/2020
General meeting14/06/202528/06/202430/06/202319/05/202210/06/202107/07/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

26 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202414/06/202523/06/2025DutchPDF
Full model31/12/202328/06/202431/07/2024DutchPDF
Full model31/12/202230/06/202311/07/2023DutchPDF
Full model31/12/202119/05/202222/06/2022DutchPDF
Full model31/12/202010/06/202124/06/2021DutchPDF
Full model31/12/201907/07/202016/07/2020DutchPDF
Full model31/12/201826/06/201911/07/2019DutchPDF
Full model31/12/201729/06/201819/07/2018DutchPDF
Full model31/12/201605/10/201709/10/2017DutchPDF
Full model31/12/201530/06/201604/07/2016DutchPDF
Full model31/12/201431/08/201514/09/2015DutchPDF
m122-f-p31/12/201431/08/201514/09/2015DutchPDF
Full model31/12/201330/06/201407/08/2014DutchPDF
m122-f-p31/12/201301/01/999907/08/2014DutchPDF
Full model31/12/201224/10/201313/12/2013DutchPDF
m122-f-p31/12/201225/10/201318/12/2013DutchPDF
Full model31/12/201126/09/201227/09/2012DutchPDF
m122-f-p31/12/201131/08/201231/08/2012DutchPDF
Full model31/12/201028/07/201107/09/2011DutchPDF
m122-f-p31/12/201028/07/201123/12/2011DutchPDF
Full model31/12/200914/07/201029/10/2010DutchPDF
m122-f-p31/12/200920/05/201021/12/2010DutchPDF
Full model31/12/200830/06/200910/08/2009DutchPDF
Full model31/12/200703/09/200806/10/2008DutchPDF

View all 26 filings

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 31 ended

Active mandates

peeters mathieu management

Director · since 31 décembre 2022 · 0876.728.461

Represented by Mathieu Peeters

Active

Ended mandates

peeters mathieu management

Director · since 31 décembre 2022 · until 31 décembre 2028 · 0876.728.461

Represented by Mathieu Peeters

Ended
BXI

Director · since 13 juillet 2018 · until 31 décembre 2022 · 0890.875.021

Represented by Ivo Lemmens

Ended
BXI

Director · since 13 juillet 2018 · until 13 juillet 2024 · 0890.875.021

Represented by Ivo Lemmens

Ended
BXI

Director · since 13 juillet 2018 · until 13 juillet 2024 · 0890.875.021

Represented by Ivo Lemmens

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other12/03/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates21/06/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/07/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/11/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/12/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates01/08/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/04/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates26/01/2018
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024178,9 k €
  2. 2023
    Annual accounts 202341,8 k €
  3. 2022
    Annual accounts 2022147,3 k €
  4. 2021
    Annual accounts 2021485,5 k €
  5. 2020
    Annual accounts 2020327,2 k €
  6. 2019
    Annual accounts 2019674 k €
  7. 2018
    Annual accounts 2018935,5 k €
  8. 2017
    Annual accounts 2017275,4 k €
  9. 2017
    Name changePharma Base
  10. 2010
    Annual accounts 2010728,4 k €
  11. 2009
    Annual accounts 200920,8 k €
  12. 2008
    Annual accounts 2008-6,9 k €
  13. 2007
    Annual accounts 2007-102 k €
  14. 2007
    Name changePATRONA PHARMA
  15. 2006
    Annual accounts 2006-61,9 k €
  16. 2006
    Name changePATRONA PHARMA GROUP INTERNATIONAL
  17. 10/10/1990
    IncorporationPublic limited company